Details of the Drug Reposition

General Information of This Drug (ID: DMDBX5F)

Drug Name
Ivermectin   DMDBX5F
Synonyms I 8898; Ivexterm (TN); MK-933; Mectizan (TN); Stromectol (TN)
Therapeutic Class
Antiprotozoal Agents
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Strongyloidiasis DIS261VG N.A. Approved [1]
Onchocerciasis DISEPYEA 1F6A Approved [2]
------------------------------------------------------------------------------------
1 Phase 2/3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Coronavirus Disease 2019 (COVID-19) DISM7GNX 1D6Y Phase 2/3 [3]
------------------------------------------------------------------------------------

References

1 Ivermectin FDA Label
2 FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (NDA) 202736
3 ClinicalTrials.gov (NCT04351347) The Efficacy of Ivermectin and Nitazoxanide in COVID-19 Treatment. U.S. National Institutes of Health.